Welcome to kongre.net
Speaker
Chief Scientific Officer, Lytix Biopharma AS
Baldur Sveinbjornsosn, Chief Scientific Officer at Lytix Biopharma AS, is speaking at 15th Tumour Models London Summit 2026 (London, United Kingdom, 2–3 Dec 2026) in the session “Evidence – Understanding Which Models Best Predict Systemic Responses to Intratumoral Immunotherapies”.
2–3 Dec 2026London, United Kingdom
Chief Scientific Officer, Immunokey
Senior Leader-Head of Translational Pharmacology, Roche
Chief Scientific Officer, Hemispherian
Director, Non-Clinical Projects Operations, Eli Lilly & Co.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Baldur Sveinbjornsosn, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].